Global Molecular Influenza Diagnostic Market Size, Status and Forecast 2020-2026

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Molecular Influenza Diagnostic Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Molecular Influenza Diagnostic Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Reverse Transcription Polymerase Chain Reaction (RT-PCR)
  • 1.4.3 Nucleic Acid Sequence Based Amplification (NASBA) Tests
  • 1.4.4 Loop-mediated Isothermal Amplification-Based Assays (LAMP)
  • 1.4.5 Simple Amplification-based Assays (SAMBA)
• 1.5 Market by Application
  • 1.5.1 Global Molecular Influenza Diagnostic Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 POCT
  • 1.5.4 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends by Regions

• 2.1 Molecular Influenza Diagnostic Market Perspective (2015-2026)
• 2.2 Molecular Influenza Diagnostic Growth Trends by Regions
  • 2.2.1 Molecular Influenza Diagnostic Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Molecular Influenza Diagnostic Historic Market Share by Regions (2015-2020)
  • 2.2.3 Molecular Influenza Diagnostic Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Molecular Influenza Diagnostic Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Molecular Influenza Diagnostic Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Molecular Influenza Diagnostic Players by Market Size
  • 3.1.1 Global Top Molecular Influenza Diagnostic Players by Revenue (2015-2020)
  • 3.1.2 Global Molecular Influenza Diagnostic Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Molecular Influenza Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Molecular Influenza Diagnostic Market Concentration Ratio
  • 3.2.1 Global Molecular Influenza Diagnostic Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Molecular Influenza Diagnostic Revenue in 2019
• 3.3 Molecular Influenza Diagnostic Key Players Head office and Area Served
• 3.4 Key Players Molecular Influenza Diagnostic Product Solution and Service
• 3.5 Date of Enter into Molecular Influenza Diagnostic Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Molecular Influenza Diagnostic Historic Market Size by Type (2015-2020)
• 4.2 Global Molecular Influenza Diagnostic Forecasted Market Size by Type (2021-2026)

5 Molecular Influenza Diagnostic Breakdown Data by Application (2015-2026)

• 5.1 Global Molecular Influenza Diagnostic Market Size by Application (2015-2020)
• 5.2 Global Molecular Influenza Diagnostic Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Molecular Influenza Diagnostic Market Size (2015-2020)
• 6.2 Molecular Influenza Diagnostic Key Players in North America (2019-2020)
• 6.3 North America Molecular Influenza Diagnostic Market Size by Type (2015-2020)
• 6.4 North America Molecular Influenza Diagnostic Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Molecular Influenza Diagnostic Market Size (2015-2020)
• 7.2 Molecular Influenza Diagnostic Key Players in Europe (2019-2020)
• 7.3 Europe Molecular Influenza Diagnostic Market Size by Type (2015-2020)
• 7.4 Europe Molecular Influenza Diagnostic Market Size by Application (2015-2020)

8 China

• 8.1 China Molecular Influenza Diagnostic Market Size (2015-2020)
• 8.2 Molecular Influenza Diagnostic Key Players in China (2019-2020)
• 8.3 China Molecular Influenza Diagnostic Market Size by Type (2015-2020)
• 8.4 China Molecular Influenza Diagnostic Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Molecular Influenza Diagnostic Market Size (2015-2020)
• 9.2 Molecular Influenza Diagnostic Key Players in Japan (2019-2020)
• 9.3 Japan Molecular Influenza Diagnostic Market Size by Type (2015-2020)
• 9.4 Japan Molecular Influenza Diagnostic Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Molecular Influenza Diagnostic Market Size (2015-2020)
• 10.2 Molecular Influenza Diagnostic Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Molecular Influenza Diagnostic Market Size by Type (2015-2020)
• 10.4 Southeast Asia Molecular Influenza Diagnostic Market Size by Application (2015-2020)

11 India

• 11.1 India Molecular Influenza Diagnostic Market Size (2015-2020)
• 11.2 Molecular Influenza Diagnostic Key Players in India (2019-2020)
• 11.3 India Molecular Influenza Diagnostic Market Size by Type (2015-2020)
• 11.4 India Molecular Influenza Diagnostic Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Molecular Influenza Diagnostic Market Size (2015-2020)
• 12.2 Molecular Influenza Diagnostic Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Molecular Influenza Diagnostic Market Size by Type (2015-2020)
• 12.4 Central & South America Molecular Influenza Diagnostic Market Size by Application (2015-2020)

13Key Players Profiles

• 13.1 BD
  • 13.1.1 BD Company Details
  • 13.1.2 BD Business Overview and Its Total Revenue
  • 13.1.3 BD Molecular Influenza Diagnostic Introduction
  • 13.1.4 BD Revenue in Molecular Influenza Diagnostic Business (2015-2020))
  • 13.1.5 BD Recent Development
• 13.2 Abbott (Include Alere)
  • 13.2.1 Abbott (Include Alere) Company Details
  • 13.2.2 Abbott (Include Alere) Business Overview and Its Total Revenue
  • 13.2.3 Abbott (Include Alere) Molecular Influenza Diagnostic Introduction
  • 13.2.4 Abbott (Include Alere) Revenue in Molecular Influenza Diagnostic Business (2015-2020)
  • 13.2.5 Abbott (Include Alere) Recent Development
• 13.3 Roche
  • 13.3.1 Roche Company Details
  • 13.3.2 Roche Business Overview and Its Total Revenue
  • 13.3.3 Roche Molecular Influenza Diagnostic Introduction
  • 13.3.4 Roche Revenue in Molecular Influenza Diagnostic Business (2015-2020)
  • 13.3.5 Roche Recent Development
• 13.4 SIEMENS
  • 13.4.1 SIEMENS Company Details
  • 13.4.2 SIEMENS Business Overview and Its Total Revenue
  • 13.4.3 SIEMENS Molecular Influenza Diagnostic Introduction
  • 13.4.4 SIEMENS Revenue in Molecular Influenza Diagnostic Business (2015-2020)
  • 13.4.5 SIEMENS Recent Development
• 13.5 Analytik Jena
  • 13.5.1 Analytik Jena Company Details
  • 13.5.2 Analytik Jena Business Overview and Its Total Revenue
  • 13.5.3 Analytik Jena Molecular Influenza Diagnostic Introduction
  • 13.5.4 Analytik Jena Revenue in Molecular Influenza Diagnostic Business (2015-2020)
  • 13.5.5 Analytik Jena Recent Development
• 13.6 Quidel
  • 13.6.1 Quidel Company Details
  • 13.6.2 Quidel Business Overview and Its Total Revenue
  • 13.6.3 Quidel Molecular Influenza Diagnostic Introduction
  • 13.6.4 Quidel Revenue in Molecular Influenza Diagnostic Business (2015-2020)
  • 13.6.5 Quidel Recent Development
• 13.7 Thermo Fisher
  • 13.7.1 Thermo Fisher Company Details
  • 13.7.2 Thermo Fisher Business Overview and Its Total Revenue
  • 13.7.3 Thermo Fisher Molecular Influenza Diagnostic Introduction
  • 13.7.4 Thermo Fisher Revenue in Molecular Influenza Diagnostic Business (2015-2020)
  • 13.7.5 Thermo Fisher Recent Development
• 13.8 Meridian Bioscience
  • 13.8.1 Meridian Bioscience Company Details
  • 13.8.2 Meridian Bioscience Business Overview and Its Total Revenue
  • 13.8.3 Meridian Bioscience Molecular Influenza Diagnostic Introduction
  • 13.8.4 Meridian Bioscience Revenue in Molecular Influenza Diagnostic Business (2015-2020)
  • 13.8.5 Meridian Bioscience Recent Development
• 13.9 BioMerieux
  • 13.9.1 BioMerieux Company Details
  • 13.9.2 BioMerieux Business Overview and Its Total Revenue
  • 13.9.3 BioMerieux Molecular Influenza Diagnostic Introduction
  • 13.9.4 BioMerieux Revenue in Molecular Influenza Diagnostic Business (2015-2020)
  • 13.9.5 BioMerieux Recent Development
• 13.10 Sekisui Diagnostics
  • 13.10.1 Sekisui Diagnostics Company Details
  • 13.10.2 Sekisui Diagnostics Business Overview and Its Total Revenue
  • 13.10.3 Sekisui Diagnostics Molecular Influenza Diagnostic Introduction
  • 13.10.4 Sekisui Diagnostics Revenue in Molecular Influenza Diagnostic Business (2015-2020)
  • 13.10.5 Sekisui Diagnostics Recent Development
• 13.11 Response Biomedical
  • 10.11.1 Response Biomedical Company Details
  • 10.11.2 Response Biomedical Business Overview and Its Total Revenue
  • 10.11.3 Response Biomedical Molecular Influenza Diagnostic Introduction
  • 10.11.4 Response Biomedical Revenue in Molecular Influenza Diagnostic Business (2015-2020)
  • 10.11.5 Response Biomedical Recent Development
• 13.12 SA Scientific
  • 10.12.1 SA Scientific Company Details
  • 10.12.2 SA Scientific Business Overview and Its Total Revenue
  • 10.12.3 SA Scientific Molecular Influenza Diagnostic Introduction
  • 10.12.4 SA Scientific Revenue in Molecular Influenza Diagnostic Business (2015-2020)
  • 10.12.5 SA Scientific Recent Development

14Analyst's Viewpoints/Conclusions

15Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer